- Home
- BLSH vs TERN Comparison
BLSH vs TERN Comparison
Compare BLSH & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BLSH | TERN |
|---|---|---|
| Founded | 2020 | 2017 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 4.8B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | BLSH | TERN |
|---|---|---|
| Price | $43.14 | $52.65 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 12 |
| Target Price | ★ $51.91 | $46.49 |
| AVG Volume (30 Days) | 1.1M | ★ 10.6M |
| Earning Date | 02-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 8.04 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $64.56 | N/A |
| Revenue Next Year | $17.81 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $24.69 | $2.37 |
| 52 Week High | $74.98 | $53.19 |
Technical Indicators
Market Signals| Indicator | BLSH | TERN |
|---|---|---|
| Relative Strength Index (RSI) | 65.96 | 73.02 |
| Support Level | $41.65 | $52.42 |
| Resistance Level | $46.39 | $53.19 |
| Average True Range (ATR) | 2.23 | 0.14 |
| MACD | 0.58 | -0.42 |
| Stochastic Oscillator | 91.48 | 41.67 |
Price Performance
Historical ComparisonAbout BLSH Bullish Ordinary Shares
Bullish is an institutionally focused global digital asset platform focused on providing market infrastructure and information services. Its objective is to provide mission critical products and services that are designed to help institutions grow their businesses, empower individual investors, and drive the adoption of stablecoins, digital assets, and blockchain technology. It expanded its product offering to provide trusted insights, authoritative news, data, indices and transparent analysis to the digital assets industry while facilitating partnerships, investment opportunities, and community engagement through its flagship Consensus conference.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.